Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review
JNCI: Journal of the National Cancer Institute · 01.07.2026 · 118 (7) · 1174-1182
DOI: 10.1093/jnci/djag025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 02.02.2026. Verfasst von Matthew C Ward und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Neoplasm Recurrence, Local, Salvage Therapy, Neoplasms, Second Primary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute of the National Institutes of Health.
Abstract (Originalsprache)
Despite decades of progress in the treatment of head and neck cancer, recurrence and second primary cancers continue to occur. The management of nonmetastatic, locoregionally recurrent or second primary cancers is a complex multidisciplinary challenge that often occurs without guidance from robust clinical trials. In 2023, the NRG Oncology cooperative group created the Recurrent and Metastatic Working Group with the express directive to investigate how resources could optimally address the key questions for the recurrent and metastatic populations. Here, we present our view of the state of the science and present considerations for future investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
- Southeast Radiation Oncology Group, PA, Charlotte, NC, United States.
- Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, United States.
- Department of Hematology and Medical Oncology, The Winship Cancer Institute, Emory University, Atlanta, GA, United States.
- Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States.
- Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer, Houston, TX, United States.
ORCID-Profile: Matthew C Ward, Jung Julie Kang, Nabil F Saba, Shauna R Campbell, Neal S Akhave, Steven S Chang, Anna Spreafico, Glenn J Hanna, Sue S Yom, Dwight E Heron
Förderung
- NCI NIH HHS
- National Cancer Institute of the National Institutes of Health
Zitieren
APA
Ward, M. C., Kang, J. J., Saba, N. F., Campbell, S. R., Akhave, N. S., Chang, S. S., Spencer, S. A., Spreafico, A., Hanna, G. J., Yom, S. S., & Heron, D. E. (2026). Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review. JNCI: Journal of the National Cancer Institute, 118(7), 1174-1182. https://doi.org/10.1093/jnci/djag025
Vancouver
Ward MC, Kang JJ, Saba NF, Campbell SR, Akhave NS, Chang SS, et al. Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review. JNCI: Journal of the National Cancer Institute. 2026;118(7):1174-1182. doi:10.1093/jnci/djag025
BibTeX
@article{Ward2026,
author = {Ward, Matthew C and Kang, Jung Julie and Saba, Nabil F and Campbell, Shauna R and Akhave, Neal S and Chang, Steven S and Spencer, Sharon A and Spreafico, Anna and Hanna, Glenn J and Yom, Sue S and Heron, Dwight E},
title = {Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2026},
volume = {118},
number = {7},
pages = {1174--1182},
doi = {10.1093/jnci/djag025}
}
EUVIMED